Publication: INTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN A SERIES OF 471 PATIENTS WITH GIANT CELL ARTERITIS
No Thumbnail Available
Identifiers
Date
2022-06-01
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Bmj publishing group